Liquid Biopsy at the Frontier of Kidney Diseases: Application of Exosomes in Diagnostics and Therapeutics

Overview

Journal Genes (Basel)

Publisher MDPI

Date 2023 Jul 29

PMID 37510273

Authors

Ewud Agborbesong

John Bissler

Xiaogang Li

Affiliations

Soon will be listed here.

Abstract

In the era of precision medicine, liquid biopsy techniques, especially the use of urine analysis, represent a paradigm shift in the identification of biomarkers, with considerable implications for clinical practice in the field of nephrology. In kidney diseases, the use of this non-invasive tool to identify specific and sensitive biomarkers other than plasma creatinine and the glomerular filtration rate is becoming crucial for the diagnosis and assessment of a patient's condition. In recent years, studies have drawn attention to the importance of exosomes for diagnostic and therapeutic purposes in kidney diseases. Exosomes are nano-sized extracellular vesicles with a lipid bilayer structure, composed of a variety of biologically active substances. In the context of kidney diseases, studies have demonstrated that exosomes are valuable carriers of information and are delivery vectors, rendering them appealing candidates as biomarkers and drug delivery vehicles with beneficial therapeutic outcomes for kidney diseases. This review summarizes the applications of exosomes in kidney diseases, emphasizing the current biomarkers of renal diseases identified from urinary exosomes and the therapeutic applications of exosomes with reference to drug delivery and immunomodulation. Finally, we discuss the challenges encountered when using exosomes for therapeutic purposes and how these may affect its clinical applications.

Citing Articles

Towards clinical translation of urinary vitronectin for non-invasive detection and monitoring of renal fibrosis in kidney transplant patients.

Clos-Sansalvador M, Taco O, Rodriguez-Martinez P, Garcia S, Font-Moron M, Bover J J Transl Med. 2024; 22(1):1030.

PMID: 39548536 PMC: 11566717. DOI: 10.1186/s12967-024-05777-5.

Urinary exosomes: a promising biomarker of drug-induced nephrotoxicity.

Zhou Z, Zhang D, Wang Y, Liu C, Wang L, Yuan Y Front Med (Lausanne). 2023; 10:1251839.

PMID: 37809338 PMC: 10556478. DOI: 10.3389/fmed.2023.1251839.

References

Liga A, Vliegenthart A, Oosthuyzen W, Dear J, Kersaudy-Kerhoas M . Exosome isolation: a microfluidic road-map. Lab Chip. 2015; 15(11):2388-94. DOI: 10.1039/c5lc00240k. View

Martinez-Greene J, Hernandez-Ortega K, Quiroz-Baez R, Resendis-Antonio O, Pichardo-Casas I, Sinclair D . Quantitative proteomic analysis of extracellular vesicle subgroups isolated by an optimized method combining polymer-based precipitation and size exclusion chromatography. J Extracell Vesicles. 2021; 10(6):e12087. PMC: 8077108. DOI: 10.1002/jev2.12087. View

Wubbolts R, Leckie R, Veenhuizen P, Schwarzmann G, Mobius W, Hoernschemeyer J . Proteomic and biochemical analyses of human B cell-derived exosomes. Potential implications for their function and multivesicular body formation. J Biol Chem. 2003; 278(13):10963-72. DOI: 10.1074/jbc.M207550200. View

Munich S, Sobo-Vujanovic A, Buchser W, Beer-Stolz D, Vujanovic N . Dendritic cell exosomes directly kill tumor cells and activate natural killer cells via TNF superfamily ligands. Oncoimmunology. 2012; 1(7):1074-1083. PMC: 3494621. DOI: 10.4161/onci.20897. View

Takov K, Yellon D, Davidson S . Comparison of small extracellular vesicles isolated from plasma by ultracentrifugation or size-exclusion chromatography: yield, purity and functional potential. J Extracell Vesicles. 2019; 8(1):1560809. PMC: 6327926. DOI: 10.1080/20013078.2018.1560809. View

Wang Z, Wu H, Fine D, Schmulen J, Hu Y, Godin B . Ciliated micropillars for the microfluidic-based isolation of nanoscale lipid vesicles. Lab Chip. 2013; 13(15):2879-82. PMC: 3740541. DOI: 10.1039/c3lc41343h. View

Yu Y, Bai F, Qin N, Liu W, Sun Q, Zhou Y . Non-Proximal Renal Tubule-Derived Urinary Exosomal miR-200b as a Biomarker of Renal Fibrosis. Nephron. 2018; 139(3):269-282. DOI: 10.1159/000487104. View

Lv L, Feng Y, Wu M, Wang B, Li Z, Zhong X . Exosomal miRNA-19b-3p of tubular epithelial cells promotes M1 macrophage activation in kidney injury. Cell Death Differ. 2019; 27(1):210-226. PMC: 7206053. DOI: 10.1038/s41418-019-0349-y. View

Pathan M, Fonseka P, Chitti S, Kang T, Sanwlani R, Van Deun J . Vesiclepedia 2019: a compendium of RNA, proteins, lipids and metabolites in extracellular vesicles. Nucleic Acids Res. 2018; 47(D1):D516-D519. PMC: 6323905. DOI: 10.1093/nar/gky1029. View

10.

Kashani K, Al-Khafaji A, Ardiles T, Artigas A, Bagshaw S, Bell M . Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury. Crit Care. 2013; 17(1):R25. PMC: 4057242. DOI: 10.1186/cc12503. View

11.

Hogan M, Manganelli L, Woollard J, Masyuk A, Masyuk T, Tammachote R . Characterization of PKD protein-positive exosome-like vesicles. J Am Soc Nephrol. 2009; 20(2):278-88. PMC: 2637052. DOI: 10.1681/ASN.2008060564. View

12.

Thongboonkerd V . Roles for Exosome in Various Kidney Diseases and Disorders. Front Pharmacol. 2020; 10:1655. PMC: 7005210. DOI: 10.3389/fphar.2019.01655. View

13.

Kurahashi R, Kadomatsu T, Baba M, Hara C, Itoh H, Miyata K . MicroRNA-204-5p: A novel candidate urinary biomarker of Xp11.2 translocation renal cell carcinoma. Cancer Sci. 2019; 110(6):1897-1908. PMC: 6549932. DOI: 10.1111/cas.14026. View

14.

Krause M, Rak-Raszewska A, Naillat F, Saarela U, Schmidt C, Ronkainen V . Exosomes as secondary inductive signals involved in kidney organogenesis. J Extracell Vesicles. 2018; 7(1):1422675. PMC: 5795705. DOI: 10.1080/20013078.2017.1422675. View

15.

Ostrowski M, Carmo N, Krumeich S, Fanget I, Raposo G, Savina A . Rab27a and Rab27b control different steps of the exosome secretion pathway. Nat Cell Biol. 2009; 12(1):19-30. DOI: 10.1038/ncb2000. View

16.

Simon C, Greening D, Bolumar D, Balaguer N, Salamonsen L, Vilella F . Extracellular Vesicles in Human Reproduction in Health and Disease. Endocr Rev. 2018; 39(3):292-332. DOI: 10.1210/er.2017-00229. View

17.

Burnham P, Dadhania D, Heyang M, Chen F, Westblade L, Suthanthiran M . Urinary cell-free DNA is a versatile analyte for monitoring infections of the urinary tract. Nat Commun. 2018; 9(1):2412. PMC: 6010457. DOI: 10.1038/s41467-018-04745-0. View

18.

Zhu H, Liao J, Zhou X, Hong X, Song D, Hou F . Tenascin-C promotes acute kidney injury to chronic kidney disease progression by impairing tubular integrity via αvβ6 integrin signaling. Kidney Int. 2020; 97(5):1017-1031. PMC: 8112450. DOI: 10.1016/j.kint.2020.01.026. View

19.

Du Cheyron D, Daubin C, Poggioli J, Ramakers M, Houillier P, Charbonneau P . Urinary measurement of Na+/H+ exchanger isoform 3 (NHE3) protein as new marker of tubule injury in critically ill patients with ARF. Am J Kidney Dis. 2003; 42(3):497-506. DOI: 10.1016/s0272-6386(03)00744-3. View

20.

Tayoun T, Faugeroux V, Oulhen M, Aberlenc A, Pawlikowska P, Farace F . CTC-Derived Models: A Window into the Seeding Capacity of Circulating Tumor Cells (CTCs). Cells. 2019; 8(10). PMC: 6829286. DOI: 10.3390/cells8101145. View